RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Lynn Francesconi to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Lynn Francesconi has written about Xenograft Model Antitumor Assays.
Lynn Francesconi
Connection Strength
0.093
Xenograft Model Antitumor Assays
  1. Ballard B, Jiang Z, Soll CE, Revskaya E, Cutler CS, Dadachova E, Francesconi LC. In vitro and in vivo evaluation of melanin-binding decapeptide 4B4 radiolabeled with 177Lu, 166Ho, and 153Sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma. Cancer Biother Radiopharm. 2011 Oct; 26(5):547-56.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support